Kopsia teoi
Kopsia teoi · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Kopsia teoi is a botanical species that has garnered significant scientific interest due to its unique pharmacological potential. Research has specifically highlighted the plant's antihypertensive activities, offering a natural approach to managing blood pressure. Central to these effects is the presence of the specific chemical compound known as kopsingine. In laboratory studies, this substance has demonstrated measurable results when administered to spontaneously hypertensive rats. Consequently, the plant represents a promising subject for further investigation into cardiovascular health treatments.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Apocynaceae
- Distribution
- Europe
- Plant Parts
- Not available
Classification
Taxonomy
Kopsia teoi is a distinctive member of the kingdom Plantae. Within this vast biological realm, the species is classified under the class Equisetopsida. It belongs to the specific genus Kopsia, which helps scientists identify its unique characteristics. Further taxonomic grouping places the plant within the order Gentianales. Ultimately, it is recognized as a proud representative of the Apocynaceae family.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Apocynaceae |
| Genus | Kopsia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Kopsia teoi is a botanical species primarily found within the lush environments of tropical Asia. Its geographic distribution is specifically concentrated throughout the Malesia region, highlighting its importance to local biodiversity. Within these humid landscapes, the plant can be frequently identified across the territories of Malaya. This specific range suggests that the species thrives under the unique climatic conditions characteristic of these Southeast Asian habitats. Understanding its localized presence is essential for studying the broader ecological patterns of the region.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Kopsia teoi is a self-supporting plant characterized by its distinct shrub growth form. This species typically reaches a maximum height of 4 meters as it matures. Its sturdy structure allows it to stand firmly within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Kopsia teoi has demonstrated significant medicinal potential through its documented antihypertensive activity. Research indicates that the aspidofractinine-type alkaloid kopsingine, derived from this plant, produces dose-related decreases in both mean arterial blood pressure and heart rate. Studies involving spontaneously hypertensive rats show that these hypotensive responses are consistent with those observed in normotensive controls. While minor structural modifications to the alkaloid do not diminish these effects, more drastic chemical changes can conversely lead to increased blood pressure. Ultimately, the plant's ability to lower blood pressure is attributed to a complex combination of both central and peripheral actions.
Compounds
Kopsia teoi is a botanical source known to contain several significant aspidofractinine-type alkaloids. Among these chemical constituents, the plant yields kopsingine, which has been shown to produce dose-related decreases in blood pressure and heart rate. In addition to kopsingine, Kopsia teoi also contains kopsaporine, a structural derivative that maintains similar hypotensive responses. The plant further produces kopsidine A, a heptacyclic compound that stands out due to its ability to increase blood pressure. Together, these diverse alkaloids demonstrate the complex cardiovascular potential inherent in the chemistry of Kopsia teoi.
Conditions
Kopsia teoi contains aspidofractinine-type alkaloids that demonstrate significant cardiovascular effects in animal models. Specifically, the alkaloid kopsingine extracted from this plant produces dose-related decreases in both mean arterial blood pressure and heart rate when injected into spontaneously hypertensive rats. These hypotensive responses are maintained even when the molecular structure undergoes minor modifications, such as in the derivatives kopsaporine and 14,15-dihydrokopsingine. However, more drastic structural changes to these compounds can reverse this effect and lead to an increase in blood pressure. Ultimately, the ability of kopsingine and its related congeners to treat hypertensive symptoms is attributed to both central and peripheral biological actions.